Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma

Abstract

Patients with hepatocellular carcinoma (HCC) beyond the traditional criteria (advanced HCC) are typically offered palliation, which is associated with a 3-year survival rate lower than 30%. This study aimed to describe the outcomes for a subset of patients with advanced HCC who satisfied the Extended Toronto Criteria (ETC) and were listed for liver… (More)
DOI: 10.1245/s10434-017-5789-3

Topics

5 Figures and Tables

Cite this paper

@article{MBBS2017LiverTI, title={Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma}, author={MRCP MRCP PhD Aloysious D. Aravinthan MBBS and Silvio Giancarlo Bruni and Adam C. Doyle and MPH PhD Hla-Hla Thein and Nicol{\'a}s Goldaracena and Assaf Issachar and MD FRCPC Leslie B. Lilly MSc and PhD Nazia Selzner and MSc FRCPC Mamatha Bhat and Boraiah Sreeharsha and Markus Selzner and PhD FRCSC Anand Ghanekar and MSc FRCSC Mark S. Cattral and FRCSC PhD Ian D. McGilvray and FRCSC FACS Paul D. Greig and FRCPC Eberhard L. Renner and FRCSC David R. Grant and Gonzalo Sapisoch{\'i}n}, journal={Annals of Surgical Oncology}, year={2017}, volume={24}, pages={1843-1851} }